Literature DB >> 30262559

Highly sensitive methods are required to detect mutations in histiocytoses.

Sarah Melloul1, Zofia Hélias-Rodzewicz1,2, Fleur Cohen-Aubart3,4, Frédéric Charlotte3,5, Sylvie Fraitag6, Nathalie Terrones1,2, Quentin Riller4, Thibaud Chazal4, Sébastien Héritier1,7, Anne Moreau8, Marianne Kambouchner9, Marie Christine Copin10, Jean Donadieu1,7, Valérie Taly11, Zahir Amoura3,4, Julien Haroche3,4, Jean François Emile12,2.   

Abstract

Year:  2018        PMID： 30262559      PMCID： PMC6395340          DOI： 10.3324/haematol.2018.201194

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease.

Authors:  Jean-François Emile; Eli L Diamond; Zofia Hélias-Rodzewicz; Fleur Cohen-Aubart; Frédéric Charlotte; David M Hyman; Eunhee Kim; Raajit Rampal; Minal Patel; Chezi Ganzel; Shlomzion Aumann; Gladwys Faucher; Catherine Le Gall; Karen Leroy; Magali Colombat; Jean-Emmanuel Kahn; Salim Trad; Philippe Nizard; Jean Donadieu; Valérie Taly; Zahir Amoura; Omar Abdel-Wahab; Julien Haroche
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

Review 2.  Histiocytoses: emerging neoplasia behind inflammation.

Authors:  Julien Haroche; Fleur Cohen-Aubart; Barret J Rollins; Jean Donadieu; Frédéric Charlotte; Ahmed Idbaih; Augusto Vaglio; Omar Abdel-Wahab; Jean-François Emile; Zahir Amoura
Journal:  Lancet Oncol       Date:  2017-02       Impact factor: 41.316

3.  Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis.

Authors:  Sébastien Héritier; Zofia Hélias-Rodzewicz; Hélène Lapillonne; Nathalie Terrones; Sonia Garrigou; Corinne Normand; Mohamed-Aziz Barkaoui; Jean Miron; Geneviève Plat; Nathalie Aladjidi; Anne Pagnier; Anne Deville; Marion Gillibert-Yvert; Despina Moshous; Alain Lefèvre-Utile; Anne Lutun; Catherine Paillard; Caroline Thomas; Eric Jeziorski; Philippe Nizard; Valérie Taly; Jean-François Emile; Jean Donadieu
Journal:  Br J Haematol       Date:  2017-04-25       Impact factor: 6.998

Review 4.  Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

Authors:  Jean-François Emile; Oussama Abla; Sylvie Fraitag; Annacarin Horne; Julien Haroche; Jean Donadieu; Luis Requena-Caballero; Michael B Jordan; Omar Abdel-Wahab; Carl E Allen; Frédéric Charlotte; Eli L Diamond; R Maarten Egeler; Alain Fischer; Juana Gil Herrera; Jan-Inge Henter; Filip Janku; Miriam Merad; Jennifer Picarsic; Carlos Rodriguez-Galindo; Barret J Rollins; Abdellatif Tazi; Robert Vassallo; Lawrence M Weiss
Journal:  Blood       Date:  2016-03-10       Impact factor: 22.113

5.  Single-agent dabrafenib for BRAFV600E-mutated histiocytosis.

Authors:  Ankush Bhatia; Gary Ulaner; Raajit Rampal; David M Hyman; Omar Abdel-Wahab; Benjamin H Durham; Ahmet Dogan; Neval Ozkaya; Mario E Lacouture; Julio Hajdenberg; Chezi Ganzel; Eli L Diamond
Journal:  Haematologica       Date:  2018-02-22       Impact factor: 9.941

6.  Recurrent BRAF mutations in Langerhans cell histiocytosis.

Authors:  Gayane Badalian-Very; Jo-Anne Vergilio; Barbara A Degar; Laura E MacConaill; Barbara Brandner; Monica L Calicchio; Frank C Kuo; Azra H Ligon; Kristen E Stevenson; Sarah M Kehoe; Levi A Garraway; William C Hahn; Matthew Meyerson; Mark D Fleming; Barrett J Rollins
Journal:  Blood       Date:  2010-06-02       Impact factor: 22.113

7.  Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing.

Authors:  Emeline Colomba; Zofia Hélias-Rodzewicz; Andreas Von Deimling; Cristi Marin; Nathalie Terrones; Dominique Pechaud; Sylvie Surel; Jean-François Côté; Frédérique Peschaud; David Capper; Hélène Blons; Ute Zimmermann; Thierry Clerici; Philippe Saiag; Jean-François Emile
Journal:  J Mol Diagn       Date:  2012-11-15       Impact factor: 5.568

8.  Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.

Authors:  Eli L Diamond; Benjamin H Durham; Julien Haroche; Zhan Yao; Jing Ma; Sameer A Parikh; Zhaoming Wang; John Choi; Eunhee Kim; Fleur Cohen-Aubart; Stanley Chun-Wei Lee; Yijun Gao; Jean-Baptiste Micol; Patrick Campbell; Michael P Walsh; Brooke Sylvester; Igor Dolgalev; Olga Aminova; Adriana Heguy; Paul Zappile; Joy Nakitandwe; Chezi Ganzel; James D Dalton; David W Ellison; Juvianee Estrada-Veras; Mario Lacouture; William A Gahl; Philip J Stephens; Vincent A Miller; Jeffrey S Ross; Siraj M Ali; Samuel R Briggs; Omotayo Fasan; Jared Block; Sebastien Héritier; Jean Donadieu; David B Solit; David M Hyman; José Baselga; Filip Janku; Barry S Taylor; Christopher Y Park; Zahir Amoura; Ahmet Dogan; Jean-Francois Emile; Neal Rosen; Tanja A Gruber; Omar Abdel-Wahab
Journal:  Cancer Discov       Date:  2015-11-13       Impact factor: 39.397

9.  Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.

Authors:  Rikhia Chakraborty; Oliver A Hampton; Xiaoyun Shen; Stephen J Simko; Albert Shih; Harshal Abhyankar; Karen Phaik Har Lim; Kyle R Covington; Lisa Trevino; Ninad Dewal; Donna M Muzny; Harshavardhan Doddapaneni; Jianhong Hu; Linghua Wang; Philip J Lupo; M John Hicks; Diana L Bonilla; Karen C Dwyer; Marie-Luise Berres; Poulikos I Poulikakos; Miriam Merad; Kenneth L McClain; David A Wheeler; Carl E Allen; D Williams Parsons
Journal:  Blood       Date:  2014-09-08       Impact factor: 22.113

10.  Variations of BRAF mutant allele percentage in melanomas.

Authors:  Zofia Hélias-Rodzewicz; Elisa Funck-Brentano; Laure Baudoux; Chan Kwon Jung; Ute Zimmermann; Cristi Marin; Thierry Clerici; Catherine Le Gall; Frédérique Peschaud; Valérie Taly; Philippe Saiag; Jean-François Emile
Journal:  BMC Cancer       Date:  2015-07-04       Impact factor: 4.430
View more
  5 in total

Review 1.  Erdheim-Chester disease: a rapidly evolving disease model.

Authors:  Francesco Pegoraro; Matthias Papo; Valerio Maniscalco; Frédéric Charlotte; Julien Haroche; Augusto Vaglio
Journal:  Leukemia       Date:  2020-06-26       Impact factor: 11.528

Review 2.  Erdheim-Chester Disease: a Concise Review.

Authors:  Matthias Papo; Jean-François Emile; Thiago Trovati Maciel; Pierre Bay; Alistair Baber; Olivier Hermine; Zahir Amoura; Julien Haroche
Journal:  Curr Rheumatol Rep       Date:  2019-12-05       Impact factor: 4.592

3.  Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease.

Authors:  Jithma P Abeykoon; Terra L Lasho; Surendra Dasari; Karen L Rech; Wasantha K Ranatunga; Michelle K Manske; Alexander Tischer; Aishwarya Ravindran; Jason R Young; William Oliver Tobin; Eoin P Flanagan; Kevin E Nowakowski; Gordon J Ruan; Mithun V Shah; Nabila Nora Bennani; Robert Vassallo; Jay H Ryu; Matthew J Koster; Caroline J Davidge-Pitts; Mrinal M Patnaik; Xiaosheng Wu; Thomas E Witzig; Gaurav Goyal; Ronald S Go
Journal:  Am J Hematol       Date:  2022-01-03       Impact factor: 13.265

Review 4.  Histiocytosis.

Authors:  Jean-François Emile; Fleur Cohen-Aubart; Matthew Collin; Sylvie Fraitag; Ahmed Idbaih; Omar Abdel-Wahab; Barrett J Rollins; Jean Donadieu; Julien Haroche
Journal:  Lancet       Date:  2021-04-23       Impact factor: 202.731

5.  Case Report: Evolution of a Severe Vascular Refractory Form of ECD Requiring Liver Transplantation Correlated With the Change in the Monocyte Subset Analysis.

Authors:  Jérôme Razanamahery; Anne Roggy; Jean-François Emile; Alexandre Malakhia; Zaher Lakkis; Francine Garnache-Ottou; Thibaud Soumagne; Fleur Cohen-Aubart; Julien Haroche; Bernard Bonnotte
Journal:  Front Immunol       Date:  2021-11-12       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.